Institutional
DIADEMA PARTNERS LP
CIK 0002026172
$587.7M
Reported AUM
111
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · DIADEMA PARTNERS LP · Q1 2026
AI · grounded in 13F
DIADEMA PARTNERS LP closed its position in XBI for a reduction of $30.48M. The fund also exited positions in PRAX and Avidity Biosciences Inc, totaling $29.65M and $23.66M respectively. On the buy side, the fund established new positions in BridgeBio Pharma Inc [[stock:BBIO 1.75 03/01/31]] for $18.57M and CYTK for $16.48M. Additionally, the fund increased its holdings in LQDA by 3,154.42%.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP DEL | $524.70 | 0.20% | 76.90% | 142.27% | $51.9M | 8.83% | — | HELD |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | $483.33 | -1.44% | 4.59% | 141.32% | $43.3M | 7.37% | — | HELD |
| 3 | VKTX | VIKING THERAPEUTICS INC | $33.43 | -1.27% | 2.29% | 405.75% | $38.5M | 6.56% | — | HELD |
| 4 | CAPR | CAPRICOR THERAPEUTICS INC | $6.57 | 0.00% | -16.84% | 31.14% | $31.4M | 5.34% | — | HELD |
| 5 | ABVX | ABIVAX SA | $118.84 | -4.34% | 65.18% | 1070.84% | $30.5M | 5.19% | — | HELD |
| 6 | LQDA | LIQUIDIA CORPORATION | $86.82 | 0.00% | 386.00% | 3118.16% | $26.9M | 4.57% | — | HELD |
| 7 | RVMD | REVOLUTION MEDICINES INC | $180.92 | -1.60% | 393.91% | 521.93% | $20.1M | 3.41% | — | HELD |
| 8 | APGE | APOGEE THERAPEUTICS INC | $134.20 | 0.02% | 255.42% | 484.87% | $18.7M | 3.19% | — | HELD |
| 9 | BBIO 1.75 03/01/31 | BRIDGEBIO PHARMA INC | — | — | — | — | $18.6M | 3.16% | — | HELD |
| 10 | INCY | INCYTE CORP | $127.10 | -2.18% | 71.89% | 69.87% | $17.3M | 2.94% | — | HELD |
| 11 | KOD | KODIAK SCIENCES INC | $40.01 | -0.69% | 501.65% | -57.52% | $16.8M | 2.85% | — | HELD |
| 12 | CYTK | CYTOKINETICS INC | $78.39 | -1.33% | 115.51% | 139.82% | $16.5M | 2.80% | — | HELD |
| 13 | JNJ | JOHNSON & JOHNSON | $265.53 | -0.45% | 64.28% | 77.25% | $13.1M | 2.24% | — | HELD |
| 14 | COGT | COGENT BIOSCIENCES INC | $39.57 | -2.70% | 247.33% | 378.21% | $12.4M | 2.11% | — | HELD |
| 15 | MRK | MERCK & CO INC | $130.36 | -1.11% | 70.49% | 100.41% | $12.0M | 2.05% | — | HELD |
| 16 | JAZZ | JAZZ PHARMACEUTICALS PLC | $255.97 | -0.37% | 121.65% | 94.40% | $10.4M | 1.76% | — | HELD |
| 17 | GPCR | STRUCTURE THERAPEUTICS INC | $47.35 | -1.13% | 169.19% | 99.03% | $9.6M | 1.64% | — | HELD |
| 18 | 430 | TERNS PHARMACEUTICALS INC | — | — | — | — | $9.6M | 1.63% | — | HELD |
| 19 | QURE | UNIQURE NV | $40.07 | 9.30% | 189.56% | 36.74% | $9.5M | 1.61% | — | HELD |
| 20 | ROIV | ROIVANT SCIENCES LTD | $32.87 | -2.87% | 196.20% | 236.68% | $9.3M | 1.58% | — | HELD |
| 21 | BMRN | BIOMARIN PHARMACEUTICAL INC | $61.37 | -1.13% | 6.76% | -26.29% | $8.4M | 1.42% | — | HELD |
| 22 | MRNA | MODERNA INC | $54.49 | -2.36% | 97.39% | -85.53% | $8.1M | 1.38% | — | HELD |
| 23 | TGTX | TG THERAPEUTICS INC | $53.48 | -2.53% | 53.31% | 98.34% | $6.9M | 1.17% | — | HELD |
| 24 | CORT | CORCEPT THERAPEUTICS INC | $92.95 | -1.32% | 34.71% | 336.80% | $6.8M | 1.16% | — | HELD |
| 25 | EWTX | EDGEWISE THERAPEUTICS INC | $39.75 | -1.49% | 177.78% | 150.95% | $6.7M | 1.14% | — | HELD |
| 26 | BBIO | BRIDGEBIO PHARMA INC | $83.54 | -2.35% | 77.69% | 67.97% | $6.3M | 1.08% | — | HELD |
| 27 | REPL | REPLIMUNE GROUP INC | $5.41 | 1.12% | -28.82% | -82.97% | $5.9M | 1.00% | — | HELD |
| 28 | IMCR | IMMUNOCORE HLDGS PLC | $33.42 | -0.27% | 0.23% | -4.33% | $5.8M | 0.99% | — | HELD |
| 29 | LLY | ELI LILLY & CO | $1210.02 | -0.87% | 61.25% | 393.83% | $5.5M | 0.94% | — | HELD |
| 30 | ABBV | ABBVIE INC | $263.30 | 0.04% | 40.72% | 165.04% | $5.2M | 0.89% | — | HELD |
| 31 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $8.92 | -1.82% | — | — | $5.2M | 0.89% | — | HELD |
| 32 | RCUS | ARCUS BIOSCIENCES INC | $26.45 | -2.22% | — | — | $5.1M | 0.88% | — | HELD |
| 33 | CRVS | CORVUS PHARMACEUTICALS INC | $13.04 | -2.03% | — | — | $5.1M | 0.87% | — | HELD |
| 34 | CRSP | CRISPR THERAPEUTICS AG | $47.64 | 0.19% | — | — | $5.1M | 0.86% | — | HELD |
| 35 | PCVX | VAXCYTE INC | $52.98 | -2.97% | — | — | $4.5M | 0.77% | — | HELD |
| 36 | EYPT | EYEPOINT INC | $11.92 | -0.33% | — | — | $3.7M | 0.62% | — | HELD |
| 37 | ZYME | ZYMEWORKS INC | $22.01 | -2.65% | — | — | $3.6M | 0.61% | — | HELD |
| 38 | GLUE | MONTE ROSA THERAPEUTICS INC | $21.56 | -2.18% | — | — | $3.1M | 0.52% | — | HELD |
| 39 | ALMS | ALUMIS INC | $26.38 | -2.40% | — | — | $2.9M | 0.49% | — | HELD |
| 40 | TENX | TENAX THERAPEUTICS INC | $14.82 | -6.20% | — | — | $2.9M | 0.49% | — | HELD |
| 41 | ANNX | ANNEXON INC | $4.86 | -2.21% | — | — | $2.7M | 0.46% | — | HELD |
| 42 | BHVN | BIOHAVEN LTD | $13.43 | -2.47% | — | — | $2.7M | 0.46% | — | HELD |
| 43 | CELC | CELCUITY INC | $83.26 | 0.97% | — | — | $2.6M | 0.45% | — | HELD |
| 44 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $35.86 | 0.25% | — | — | $2.6M | 0.44% | — | HELD |
| 45 | NVO | NOVO-NORDISK A S | $51.58 | 1.22% | — | — | $2.6M | 0.44% | — | HELD |
| 46 | NTLA | INTELLIA THERAPEUTICS INC | $10.80 | -0.83% | — | — | $2.6M | 0.44% | — | HELD |
| 47 | VYGR | VOYAGER THERAPEUTICS INC | $3.00 | -1.32% | — | — | $2.2M | 0.38% | — | HELD |
| 48 | BCYC | BICYCLE THERAPEUTICS PLC | $3.86 | -2.03% | — | — | $2.2M | 0.38% | — | HELD |
| 49 | INDV | INDIVIOR PHARMACEUTICALS INC | $40.10 | -2.17% | — | — | $2.2M | 0.37% | — | HELD |
| 50 | CLYM | CLIMB BIO INC | $12.11 | -1.46% | — | — | $2.0M | 0.33% | — | HELD |
| 51 | IVA | INVENTIVA SA | $4.51 | -2.80% | — | — | $1.9M | 0.33% | — | HELD |
| 52 | STTK | SHATTUCK LABS INC | $6.76 | -0.88% | — | — | $1.9M | 0.32% | — | HELD |
| 53 | TARS | TARSUS PHARMACEUTICALS INC | $58.52 | -0.73% | — | — | $1.8M | 0.31% | — | HELD |
| 54 | ALKS | ALKERMES PLC | $48.34 | -4.28% | — | — | $1.8M | 0.30% | — | HELD |
| 55 | MGNX | MACROGENICS INC | $3.67 | -4.68% | — | — | $1.7M | 0.30% | — | HELD |
| 56 | CTMX | CYTOMX THERAPEUTICS INC. | $3.17 | -1.55% | — | — | $1.5M | 0.25% | — | HELD |
| 57 | AVXL | ANAVEX LIFE SCIENCES CORP | $2.49 | -3.11% | — | — | $1.5M | 0.25% | — | HELD |
| 58 | RLMD | RELMADA THERAPEUTICS INC | $5.14 | -1.72% | — | — | $1.4M | 0.24% | — | HELD |
| 59 | KPTI | KARYOPHARM THERAPEUTICS INC | $6.86 | -3.24% | — | — | $1.3M | 0.23% | — | HELD |
| 60 | SLS | SELLAS LIFE SCIENCES GROUP I | $10.10 | 0.10% | — | — | $1.3M | 0.22% | — | HELD |
| 61 | OLMA | OLEMA PHARMACEUTICALS INC | $11.19 | -3.70% | — | — | $1.3M | 0.21% | — | HELD |
| 62 | CRMD | CORMEDIX INC | $7.19 | -2.18% | — | — | $1.1M | 0.19% | — | HELD |
| 63 | INO | INOVIO PHARMACEUTICALS INC | $1.04 | 0.97% | — | — | $1.1M | 0.19% | — | HELD |
| 64 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $4.56 | -2.98% | — | — | $1.1M | 0.18% | — | HELD |
| 65 | BIOA | BIOAGE LABS INC | $22.19 | 1.23% | — | — | $1.0M | 0.18% | — | HELD |
| 66 | AYTU | AYTU BIOPHARMA INC | $2.08 | -2.35% | — | — | $964K | 0.16% | — | HELD |
| 67 | OCGN | OCUGEN INC | $1.19 | -4.03% | — | — | $905K | 0.15% | — | HELD |
| 68 | EQ | EQUILLIUM INC | $2.28 | -1.72% | — | — | $868K | 0.15% | — | HELD |
| 69 | DNTH | DIANTHUS THERAPEUTICS INC | $104.09 | 2.44% | — | — | $839K | 0.14% | — | HELD |
| 70 | PHVS | PHARVARIS N V | $32.62 | -3.05% | — | — | $828K | 0.14% | — | HELD |
| 71 | ENTA | ENANTA PHARMACEUTICALS INC | $12.45 | -1.27% | — | — | $820K | 0.14% | — | HELD |
| 72 | IBRX | IMMUNITYBIO INC | $6.83 | -2.01% | — | — | $815K | 0.14% | — | HELD |
| 73 | VIR | VIR BIOTECHNOLOGY INC | $8.64 | -2.37% | — | — | $796K | 0.14% | — | HELD |
| 74 | XERS | XERIS BIOPHARMA HOLDINGS INC | $8.38 | 1.70% | — | — | $770K | 0.13% | — | HELD |
| 75 | LRMR | LARIMAR THERAPEUTICS INC | $3.63 | -5.22% | — | — | $750K | 0.13% | — | HELD |
| 76 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $25.00 | -3.77% | — | — | $736K | 0.13% | — | HELD |
| 77 | MLYS | MINERALYS THERAPEUTICS INC | $26.35 | -2.23% | — | — | $714K | 0.12% | — | HELD |
| 78 | UNCY | UNICYCIVE THERAPEUTICS INC | $4.74 | -4.05% | — | — | $698K | 0.12% | — | HELD |
| 79 | SPRB | SPRUCE BIOSCIENCES INC | $41.45 | -0.36% | — | — | $654K | 0.11% | — | HELD |
| 80 | PHAT | PHATHOM PHARMACEUTICALS INC | $11.64 | -0.17% | — | — | $607K | 0.10% | — | HELD |
| 81 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $2.05 | -1.44% | — | — | $526K | 0.09% | — | HELD |
| 82 | PTHS | PELTHOS THERAPEUTICS INC | $25.74 | -7.31% | — | — | $520K | 0.09% | — | HELD |
| 83 | EOLS | EVOLUS INC | $6.03 | -3.05% | — | — | $515K | 0.09% | — | HELD |
| 84 | MNKD | MANNKIND CORP | $3.85 | -1.53% | — | — | $457K | 0.08% | — | HELD |
| 85 | MAZE | MAZE THERAPEUTICS INC | $27.27 | -2.19% | — | — | $448K | 0.08% | — | HELD |
| 86 | JANX | JANUX THERAPEUTICS INC | $14.96 | -0.27% | — | — | $439K | 0.07% | — | HELD |
| 87 | URGN | UROGEN PHARMA LTD | $40.45 | -1.05% | — | — | $416K | 0.07% | — | HELD |
| 88 | LPCN | LIPOCINE INC NEW | $2.07 | -3.27% | — | — | $400K | 0.07% | — | HELD |
| 89 | FHTX | FOGHORN THERAPEUTICS INC | $4.74 | -7.60% | — | — | $382K | 0.07% | — | HELD |
| 90 | GHRS | GH RESEARCH PLC | $27.98 | 0.07% | — | — | $377K | 0.06% | — | HELD |
| 91 | PRQR | PROQR THRAPEUTICS N V | $1.73 | -1.70% | — | — | $292K | 0.05% | — | HELD |
| 92 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $5.97 | -2.13% | — | — | $290K | 0.05% | — | HELD |
| 93 | PEPG | PEPGEN INC | $1.71 | -6.56% | — | — | $267K | 0.05% | — | HELD |
| 94 | TRVI | TREVI THERAPEUTICS INC | $18.09 | -1.84% | — | — | $258K | 0.04% | — | HELD |
| 95 | PGEN | PRECIGEN INC | $5.45 | -1.45% | — | — | $214K | 0.04% | — | HELD |
| 96 | UPB | UPSTREAM BIO INC | $6.41 | 0.16% | — | — | $194K | 0.03% | — | HELD |
| 97 | CMPS | COMPASS PATHWAYS PLC | $10.90 | 0.46% | — | — | $176K | 0.03% | — | HELD |
| 98 | PASG | PASSAGE BIO INC | $4.52 | -1.09% | — | — | $153K | 0.03% | — | HELD |
| 99 | TLPH | TALPHERA INC | $1.31 | 0.77% | — | — | $115K | 0.02% | — | HELD |
| 100 | RCKT | ROCKET PHARMACEUTICALS INC | $3.14 | 0.00% | — | — | $109K | 0.02% | — | HELD |
| 101 | MNPR | MONOPAR THERAPEUTICS INC | — | — | — | — | $89K | 0.02% | — | HELD |
| 102 | LYEL | LYELL IMMUNOPHARMA INC | — | — | — | — | $82K | 0.01% | — | HELD |
| 103 | VTGN | VISTAGEN THERAPEUTICS INC | — | — | — | — | $60K | 0.01% | — | HELD |
| 104 | RNA | ATRIUM THERAPEUTICS INC | — | — | — | — | $34K | 0.01% | — | HELD |
| 105 | CUE1EUR | CUE BIOPHARMA INC | — | — | — | — | $30K | 0.01% | — | HELD |
| 106 | ENTX | ENTERA BIO LTD | — | — | — | — | $26K | 0.00% | — | HELD |
| 107 | ATYR | ATYR PHARMA INC | — | — | — | — | $19K | 0.00% | — | HELD |
| 108 | PRTCY | PURETECH HEALTH PLC | — | — | — | — | $11K | 0.00% | — | HELD |
| 109 | ELVN | ENLIVEN THERAPEUTICS INC | — | — | — | — | $10K | 0.00% | — | HELD |
| 110 | SEPN | SEPTERNA INC | — | — | — | — | $5K | 0.00% | — | HELD |
| 111 | JBIO | JADE BIOSCIENCES INC | — | — | — | — | $3K | 0.00% | — | HELD |
Source: SEC EDGAR · accession 0001892688-26-000076. 13F discloses long positions only — shorts, foreign equities, and options are excluded.